<DOC>
	<DOCNO>NCT00869440</DOCNO>
	<brief_summary>The purpose study assess safety efficacy CNS 7056 procedural sedative three dose level compare midazolam diagnostic upper GI endoscopy .</brief_summary>
	<brief_title>Dose-Finding Safety Study Evaluating CNS 7056 Patients Undergoing Diagnostic Upper GI Endoscopy</brief_title>
	<detailed_description>This randomize , double-blind , parallel-group , dose-finding study assess safety efficacy three dose level CNS 7056 compare midazolam patient undergoing diagnostic upper GI endoscopy . Patients meet study entry criterion complete screening procedure randomly assign 1 4 treatment group : CNS 7056 0.10 mg/kg,0.15 mg/kg , 0.20 mg/kg ; midazolam 0.075 mg/kg . Patients receive assign treatment administer single intravenous injection syringe driver 1 minute . The endoscopy start Modified Observer 's Assessment Alertness/Sedation ( MOAA/S ) score ≤3 reach , earlier 90 second Time 0 ( start study drug injection ) . Rescue sedative medication ( midazolam 1-2 mg ) permit discretion administer physician . Efficacy assessment consist MOAA/S score , Aldrete score , drowsiness measure use Visual Analogue Scale ( VAS ) . Cognitive function assess HVLT-R™ memory procedure Brice Questionnaire . Safety assessment include adverse event , physical examination , vital sign , ECGs , pulse oximetry measurement , clinical laboratory test , pain injection use VAS .</detailed_description>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Male female patient , age 18 65 year inclusive , schedule undergo diagnostic upper GI endoscopy . American Society Anesthesiologists Physical Status ( ASA PS ) Score I II . Weight range 60 120 kg inclusive . Body mass index ( BMI ) 18 &lt; 30 kg/m2 . Patients clinically significant abnormality 12 lead ECG record Screening . Female negative serum human chorionic gonadotropin ( hCG ) pregnancy test result Screening negative urine hCG pregnancy test result Day 1 endoscopy procedure . Patients negative drug abuse serum result Screening negative drug abuse urine result Day 1 endoscopy procedure . Patient negative serum ethanol test result Screening negative ethanol saliva test result Day 1 endoscopy procedure . Patient voluntarily sign date ICF approve IRB prior conduct study procedure . Patient willing able comply study requirement return Follow Visit ( Visit 3 ± 1 day ) endoscopy procedure . Patients suspect upper GI bleed condition predispose hemorrhage discretion investigator . Has know sensitivity benzodiazepine , flumazenil , anesthetic agent , medical condition agent contraindicate . Patients evidence uncontrolled renal , hepatic , central nervous system , respiratory , cardiovascular , metabolic dysfunction , opinion investigator medical monitor . Patients take agent inhibits cytochrome P450 subtype 3A4 ( CYP3A4 ) patient take agent within 14 day prior study start within duration 7 half life drug , whichever longer . Patients receipt investigational drug within 30 day less 7 half life ( whichever longer ) start study , schedule receive one study period . Chronic use benzodiazepine indication ( eg , insomnia , anxiety , spasticity ) . Has know suspect history alcoholism drug abuse misuse within 2 year Screening evidence tolerance physical dependence dose study drug . Patients clinically significant finding Screening , investigator 's opinion , exclude study . Patients history laboratory result show presence hepatitis B surface antigen ( HBs Ag ) , hepatitis C antibody ( HCV Ab ) , human immunodeficiency virus ( HIV ) . Patients inability communicate well English investigator . Lactating female patient . Patients management airway judge difficult due : obesity ( weight &gt; 120 kg , BMI ≥ 30 kg/m2 ) , thyro mental distance ≤ 4 cm ( `` short neck '' ) , Mallampati score 4 ( Appendix IV ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>CNS 7056</keyword>
	<keyword>Procedural Sedation</keyword>
	<keyword>Sedation</keyword>
	<keyword>Endoscopy</keyword>
</DOC>